These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 16474176)

  • 21. Germline 657del5 mutation in the NBS1 gene in breast cancer patients.
    Górski B; Debniak T; Masojć B; Mierzejewski M; Medrek K; Cybulski C; Jakubowska A; Kurzawski G; Chosia M; Scott R; Lubiński J
    Int J Cancer; 2003 Sep; 106(3):379-81. PubMed ID: 12845677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility.
    Heikkinen K; Karppinen SM; Soini Y; Mäkinen M; Winqvist R
    J Med Genet; 2003 Dec; 40(12):e131. PubMed ID: 14684699
    [No Abstract]   [Full Text] [Related]  

  • 23. RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients.
    Fan C; Zhang J; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    Int J Cancer; 2018 Oct; 143(8):1935-1942. PubMed ID: 29726012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel NBS1 heterozygous germ line mutation causing MRE11-binding domain loss predisposes to common types of cancer.
    Ebi H; Matsuo K; Sugito N; Suzuki M; Osada H; Tajima K; Ueda R; Takahashi T
    Cancer Res; 2007 Dec; 67(23):11158-65. PubMed ID: 18056440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis.
    Ho V; Chung L; Singh A; Lea V; Abubakar A; Lim SH; Ng W; Lee M; de Souza P; Shin JS; Lee CS
    BMC Cancer; 2018 Sep; 18(1):869. PubMed ID: 30176843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations of an intronic repeat induce impaired MRE11 expression in primary human cancer with microsatellite instability.
    Giannini G; Rinaldi C; Ristori E; Ambrosini MI; Cerignoli F; Viel A; Bidoli E; Berni S; D'Amati G; Scambia G; Frati L; Screpanti I; Gulino A
    Oncogene; 2004 Apr; 23(15):2640-7. PubMed ID: 15048091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.
    Buslov KG; Iyevleva AG; Chekmariova EV; Suspitsin EN; Togo AV; Kuligina ESh; Sokolenko AP; Matsko DE; Turkevich EA; Lazareva YR; Chagunava OL; Bit-Sava EM; Semiglazov VF; Devilee P; Cornelisse C; Hanson KP; Imyanitov EN
    Int J Cancer; 2005 Apr; 114(4):585-9. PubMed ID: 15578693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cleavage of the BRCT tandem domains of nibrin by the 657del5 mutation affects the DNA damage response less than the Arg215Trp mutation.
    Mendez G; Cilli D; Berardinelli F; Viganotti M; Ascenzi P; Tanzarella C; Antoccia A; di Masi A
    IUBMB Life; 2012 Oct; 64(10):853-61. PubMed ID: 22941933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The MRN protein complex genes: MRE11 and RAD50 and susceptibility to head and neck cancers.
    Ziółkowska-Suchanek I; Mosor M; Wierzbicka M; Rydzanicz M; Baranowska M; Nowak J
    Mol Cancer; 2013 Sep; 12(1):113. PubMed ID: 24079363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal Cancer.
    Situ Y; Chung L; Lee CS; Ho V
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.
    Mantere T; Tervasmäki A; Nurmi A; Rapakko K; Kauppila S; Tang J; Schleutker J; Kallioniemi A; Hartikainen JM; Mannermaa A; Nieminen P; Hanhisalo R; Lehto S; Suvanto M; Grip M; Jukkola-Vuorinen A; Tengström M; Auvinen P; Kvist A; Borg Å; Blomqvist C; Aittomäki K; Greenberg RA; Winqvist R; Nevanlinna H; Pylkäs K
    Sci Rep; 2017 Apr; 7(1):681. PubMed ID: 28386063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.
    Wu Z; Wang P; Song C; Wang K; Yan R; Li J; Dai L
    Mol Genet Genomics; 2015 Jun; 290(3):1141-53. PubMed ID: 25566853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Envisioning the dynamics and flexibility of Mre11-Rad50-Nbs1 complex to decipher its roles in DNA replication and repair.
    Lafrance-Vanasse J; Williams GJ; Tainer JA
    Prog Biophys Mol Biol; 2015 Mar; 117(2-3):182-193. PubMed ID: 25576492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular redistribution and modification of proteins of the Mre11/Rad50/Nbs1 DNA repair complex following irradiation and heat-shock.
    Seno JD; Dynlacht JR
    J Cell Physiol; 2004 May; 199(2):157-70. PubMed ID: 15039997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of Double-strand Break Repair Gene Nijmegen Breakage Syndrome 1 Genotypes, Gender Difference and Smoking Status to Taiwanese Lung Cancer.
    Chuang CL; Wang CH; Hsu CH; Hsiao CL; Chen GL; Yen ST; Li HT; Chang WS; Tsai CW; Wang SC; Bau DT
    Anticancer Res; 2017 May; 37(5):2417-2423. PubMed ID: 28476809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population.
    Loizidou MA; Cariolou MA; Neuhausen SL; Newbold RF; Bashiardes E; Marcou Y; Michael T; Daniel M; Kakouri E; Papadopoulos P; Malas S; Hadjisavvas A; Kyriacou K
    Breast Cancer Res Treat; 2010 May; 121(1):147-56. PubMed ID: 19714462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families.
    Solyom S; Pylkäs K; Winqvist R
    Fam Cancer; 2010 Dec; 9(4):537-40. PubMed ID: 20567916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATM and the Mre11-Rad50-Nbs1 complex respond to nucleoside analogue-induced stalled replication forks and contribute to drug resistance.
    Ewald B; Sampath D; Plunkett W
    Cancer Res; 2008 Oct; 68(19):7947-55. PubMed ID: 18829552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New mutations and protein variants of NBS1 are identified in cancer cell lines.
    Tessitore A; Biordi L; Flati V; Toniato E; Marchetti P; Ricevuto E; Ficorella C; Scotto L; Giannini G; Frati L; Masciocchi C; Tombolini V; Gulino A; Martinotti S
    Genes Chromosomes Cancer; 2003 Feb; 36(2):198-204. PubMed ID: 12508248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer.
    Brandt S; Samartzis EP; Zimmermann AK; Fink D; Moch H; Noske A; Dedes KJ
    BMC Cancer; 2017 Jan; 17(1):44. PubMed ID: 28073364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.